Nicole K. Clay is a Research Scientist at Molecular, Cellular and Developmental Biology. She received her B.S. in Biology from Massachusetts Institute of Technology and her Ph.D. in Biology from Yale University. She was the Ruth L. Kirschstein Postdoctoral Fellow in the lab of Dr. Frederick M. Ausubel at Massachusetts General Hospital, an affiliate of the Harvard Medical School. As a postdoc, she began studying plant-microbe interactions and discovered immune signaling roles for an ancient class of plant chemicals. She joined the faculty at Yale University in 2011.
The Clay lab studies the plant innate immune system to identify new immune signals, regulators and systems required for robust basal and acquired plant disease resistance and the production of plant-based medicines and sustainable biofuels.
Plant innate immunity. Plants, unlike mammals, lack mobile defender cells and adaptive immune systems. Instead, they rely on the innate immunity of each cell, systemic peptide and chemical signals emanating from infection sites, and preformed and inducible chemical defenses at infection sites to ward off invading pathogens. Plant innate immunity is based on the perception and production of small molecules and rivals mammalian innate immunity in combating pathogenic infections.
Novel Immune Signals and Regulators. More than prokaryotes or animals, plants collectively produce hundreds of thousands of natural products, the majority of which are used in plant defense against microbial pathogens, insect herbivores and competitor plants. Only a tiny fraction of the plant natural product diversity is used in bioenergy, industry and human medicines. Yet, an estimated 74% of the most important human drugs in the 21st century contain plant-derived active ingredients, and about 75% of the global population still relies on plant-based traditional medicines for their primary health care. Despite their divergent structures and bioactivities, these phytochemicals are robustly integrated into the conserved framework of plant immune responses, conferring long-lasting immunity against a broad spectrum of microbes throughout the plant. The Clay lab exploits plant-pathogen interactions to discover novel immune signals and regulators of metabolite profiles required for basal and acquired disease resistance in plants.
Novel Protein Modifications and Quality-controls. Because plants and humans share the same pathways for protein synthesis, glycosylation and quality-control, plants have emerged as alternative hosts for the cost-effective, large-scale production of biopharmaceuticals and vaccines with defined human-like glycan structures. The complex ligand-binding structures of plant innate immune receptors require post-translational modifications and sophisticated protein quality control systems at multiple steps along the secretory pathway to recognize and eliminate misfolded, immature and unassembled proteins. The Clay lab studies plant immune receptors to discover novel protein modifications and quality-controls that regulate recombinant (and native) protein production and function in plants.